Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1732 results
Sengenics acquires Oxford Gene Technology’s protein array technology
Genomics and proteomics-based research and diagnostics firm Sengenics has acquired Oxford Gene Technology’s (OGT) protein array technology, a patented auto-antibody profiling platform which was spun out from research that was commercialised as a joint collaboration between the University of Oxford and the University of Cambridge in 1996.
Automation > IT & Software > News
Teva Pharmaceutical and IBM collaborate on Watson Health Cloud
By PBR Staff Writer
Teva Pharmaceutical Industries has been selected as IBM's first foundational life sciences partner for the Watson Health Cloud.
Automation > IT & Software > News
NanoString launches nCounter RNA:Protein PanCancer Immune Profiling Panel
NanoString Technologies announced the commercial launch of the nCounter RNA:Protein PanCancer Immune Profiling Panel.
Automation > IT & Software > News
Envision Pharma acquires Alligent Biopharm Consulting
Envision Pharma Group has acquired Alligent Biopharm Consulting.
Automation > IT & Software > News
Walvax adopts Medidata's technology platform for pediatric vaccine program in China
By PBR Staff Writer
Walvax Biotechnology has selected Medidata's cloud-based technology platform to advance pediatric vaccine program in China.
Automation > IT & Software > News
Agilent Technologies to buy Seahorse Bioscience
Agilent Technologies has agreed to acquire Seahorse Bioscience, which provides instruments and assay kits for measuring cell metabolism and bioenergetics.
Automation > IT & Software > News
AstraZeneca and Starpharma sign drug delivery technology deal
By PBR Staff Writer
AstraZeneca has signed a licensing agreement to use Starpharma's DEP drug delivery technology in the development and commercialization of an oncology compound on signature.
Automation > IT & Software > News
EnWave starts manufacturing phase of deal with Sutro Biopharma
By PBR Staff Writer
Canadian industrial technology firm EnWave has started manufacturing phase of agreement signed with Sutro Biopharma.
Automation > IT & Software > News
First US patient treated with Brainlab's new automatic brain metastases planning software
Brainlab's new Automatic Brain Metastases Planning software has been used for the first time in the US at Jefferson Hospital for Neuroscience in Philadelphia to deliver a tailored radiosurgery treatment to a patient with cancer that has metastasized to the brain.
Automation > IT & Software > News
Cellectis teams up with MD Anderson Cancer Center for cancer immnotherapy
By PBR Staff Writer
Cellectis, a gene editing company that uses proprietary technologies to develop CAR T-cell products in adoptive immunotherapy for cancer, and The University of Texas MD Anderson Cancer Center have formed a research and development partnership to bring new cellular immunotherapies to patients suffering from different kinds of liquid tumors.
Automation > IT & Software > News
Redx Pharma forms cancer research collaboration with Horizon Discovery Group
Redx Pharma has formed a cancer research collaboration with Horizon Discovery Group.
Automation > IT & Software > News
RedHill Biopharma gets notice of allowance for new Israeli patent covering RHB-104 to treat Crohn's disease
RedHill Biopharma has received a Notice of Allowance from the Israeli Patent Office (ILPO) for a new Israeli patent No. 207420 covering the formulation of RHB-104, a proprietary and potentially groundbreaking antibiotic combination therapy in oral capsule formulation, with potent intracellular, anti-mycobacterial and anti-inflammatory properties.
Automation > IT & Software > News
Minerva licenses Sendai Virus technology for stem cell generation
Minerva Biotechnologies and ID Pharma (formerly DNAVEC) announced that they have signed an agreement granting Minerva worldwide rights to use and commercialize their non-integrating Sendai virus vectors, together with Minerva’s proprietary technology, for generating Induced Pluripotent Stem (iPS) cells.
Automation > IT & Software > News
Allied-Bristol Life Sciences licenses Yale University's platform technology and lead molecules
By PBR Staff Writer
Allied-Bristol Life Sciences (ABLS) has entered into a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules to further developed new treatments for diseases such as prostate cancer.
Automation > IT & Software > News
Immatics, Anderson launch Immatics US to develop multiple T-cell and TCR-based adoptive cellular therapies
Immatics Biotechnologies (Immatics) and The University of Texas MD Anderson Cancer Center announced the launch of Immatics US, a new company aiming at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumor types.
Automation > IT & Software > News
91-105 of 1732 results